Early Diagnosis of Alzheimer's Disease: Moving Toward a Blood-Based Biomarkers Era

Qing-Qing Tao; Rong-Rong Lin; Zhi-Ying Wu

doi:10.2147/CIA.S394821

Early Diagnosis of Alzheimer's Disease: Moving Toward a Blood-Based Biomarkers Era

Clin Interv Aging. 2023 Mar 6:18:353-358. doi: 10.2147/CIA.S394821. eCollection 2023.

Authors

Qing-Qing Tao¹, Rong-Rong Lin¹, Zhi-Ying Wu^{1

2}

Affiliations

¹ Department of Neurology and Research Center of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, People's Republic of China.
² MOE Frontier Science Center for Brain Science and Brain-Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou, People's Republic of China.

No abstract available

Publication types

Editorial

MeSH terms

Alzheimer Disease* / diagnosis
Amyloid beta-Peptides
Biomarkers
Early Diagnosis
Humans
tau Proteins

Substances

Biomarkers
Amyloid beta-Peptides
tau Proteins

Grants and funding

This work was funded by the Science Innovation 2030-Brain Science and Brain-Inspired Intelligence Technology Major Projects (Nos.2021ZD0201103 and 2021ZD0201803) and the Key Research and Development project of Zhejiang Province (2019C03039).